Make scientific figures in minutes

Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software

search icon

Try a synonym, or sign up to request an icon from the app.

Myeloblast (acute myeloid leukemia)

Myeloblast (acute myeloid leukemia) - Editable icon of an irregular-shaped myeloblast cell with granules and two auer rods in the cytoplasm, a large irregular nucleus and two small nucleoli
[{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2099/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2099/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2098/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2098/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2097/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2097/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2096/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2096/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2095/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2095/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2094/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2094/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2093/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2093/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2092/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2092/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2091/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2091/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2090/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2090/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a208f/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a208f/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a208e/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a208e/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a208d/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a208d/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a208c/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a208c/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a208b/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a208b/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a208a/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a208a/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2089/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2089/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2088/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2088/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2087/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2087/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2086/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2086/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2085/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2085/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2084/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2084/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2083/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2083/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2082/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2082/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2081/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2081/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2080/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2080/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a207f/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a207f/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a207e/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a207e/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a207d/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a207d/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a207c/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a207c/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a207b/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a207b/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a207a/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a207a/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2079/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2079/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2078/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2078/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2077/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2077/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2076/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2076/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2075/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2075/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2074/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2074/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2073/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2073/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2072/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2072/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2071/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2071/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2070/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2070/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a206f/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a206f/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a206e/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a206e/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a206d/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a206d/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a206c/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a206c/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a206b/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a206b/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a206a/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a206a/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2069/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2069/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2068/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2068/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2067/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2067/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2066/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2066/6218fcbec443a0002909e764.png"}]
Keywords
myeloblast,myeloid blast,myeloid,granulocyte,progenitor,acute myeloblastic leukemia,leukemia,stem cell,unipotent,granules,nucleoli,nucleus,auer rod,auer,bone marrow,sinus,marrow,myeloblast
Image types

Myeloblast (acute myeloid leukemia) icon JPEG

Myeloblast (acute myeloid leukemia) icon PNG

Myeloblast (acute myeloid leukemia) icon SVG

Myeloblast (acute myeloid leukemia) icon GIF

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today
SIGN UP FREE
Decorative Chat Icon

FAQ

What is BioRender?
BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Myeloblast (acute myeloid leukemia) icon along with our library of more than 30,000 life science icons.
Can I use this icon in a BioRender figure or scientific illustration?
Yes, the Myeloblast (acute myeloid leukemia) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.
Is the Myeloblast (acute myeloid leukemia) icon customizable in BioRender?
Most icons in BioRender, including the Myeloblast (acute myeloid leukemia) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.
How are scientists using the Myeloblast (acute myeloid leukemia) icon in their work?
BioRender users often use the Myeloblast (acute myeloid leukemia) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.
Can I export figures that include the Myeloblast (acute myeloid leukemia) icon for publication or presentations?
Yes, figures containing the Myeloblast (acute myeloid leukemia) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.
Is the Myeloblast (acute myeloid leukemia) icon used in BioRender templates or poster layouts?
Many BioRender templates include icons like the Myeloblast (acute myeloid leukemia) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now